For Immediate Release
Emergent Group Inc. Reports Record Third Quarter Sales and EPS of $0.08
Quarter Results Show Strong Operating Gain
SUN VALLEY, Calif.--(PRIMENEWSWIRE)—November 14, 2007—Emergent Group Inc. (OTC BB:EMGP.OB- News), a leading provider of mobile medical lasers and surgical equipment, announced results for the third quarter ended September 30, 2007. Revenues for the quarter increased 12% to a record $4,467,011 as compared to revenues of $3,997,933 for the same period in 2006. Net income was $430,448 or $0.08 per basic share for the third quarter as compared to net income of $445,765 or $0.08 per basic share for the same period in 2006.
“We continue our ability to deliver consistent growth in a challenging economy as we recorded our eighth consecutive quarter of year over year growth in sales,” said Bruce J. Haber, Emergent Group Chairman and CEO. He added, “Most importantly, net income rebounded strongly from the last quarter as we near completion of our transition to newer and more profitable laser technology. This technology provides the company with a significantly larger margin of profitability and positions us to resume our long term trend of income growth and financial results well in excess of the industry. The Emergent Group is also in an excellent position to capitalize on new acquisition and partnership opportunities in our goal to accelerate financial performance.”
About Emergent Group Inc.
Emergent Group Inc. through its wholly owned subsidiary, PRI Medical Technologies, Inc. (“PRI Medical”) provides mobile laser and surgical equipment on a per procedure basis to hospitals, out-patient surgery centers, and physicians' offices. Surgical equipment is provided to customers along with technical support personnel to ensure that such equipment is operating correctly. PRI Medical currently offers its services in California, Nevada, Colorado, Utah and Arizona. For product and other information, visit PRI Medical’s website, http://www.primedical.net.
Forward-Looking Statements:
Statements in this news release may contain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934. Such statements may involve various risks and uncertainties, some of which may be discussed in the Company's most recent report on Form 10-KSB and subsequently filed SEC reports. There is no assurance any forward-looking statements will prove accurate, as actual results and future events could differ materially from those presently anticipated.
Investor Contact: Bruce J. Haber (914) 235-5550, x12
e-mail: bhaber@primedical.net